LEADER 03319nam 2200541 450 001 9910807749403321 005 20230803212557.0 010 $a0-309-31273-6 010 $a0-309-31271-X 035 $a(CKB)3710000000336165 035 $a(EBL)3379406 035 $a(SSID)ssj0001468602 035 $a(PQKBManifestationID)11902749 035 $a(PQKBTitleCode)TC0001468602 035 $a(PQKBWorkID)11536132 035 $a(PQKB)10154872 035 $a(MiAaPQ)EBC3379406 035 $a(EXLCZ)993710000000336165 100 $a20150121h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEnsuring patient access to affordable cancer drugs $eworkshop summary /$fSharyl J. Nass and Margie Patlak 210 1$aWashington, District of Columbia :$cThe National Academies Press,$d2014. 210 4$dİ2014 215 $a1 online resource (74 p.) 300 $aDescription based upon print version of record. 311 $a0-309-31270-1 327 $a""FrontMatter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Table""; ""Acronyms""; ""Workshop Summary""; ""Appendix: Workshop Statement of Task and Agenda"" 330 $a"In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable financially because their illness and/or treatment impedes their ability to work, with some patients losing employment altogether. Even with insurance, cancer patients often experience financial hardships, such as going into debt, depleting all assets to pay for cancer treatment, and personal bankruptcy. Although many elements contribute to the cost of cancer care, one important component is the cost of new cancer drugs, which has been escalating rapidly in recent years. To explore the issue of cancer drug costs and patient access to affordable, appropriate drug therapies, the Institute of Medicine's National Cancer Policy Forum convened a workshop on ensuring patient access to affordable cancer drugs in June 2014. Affordability was considered from both individual and societal perspectives. The workshop featured discussion panels as well as invited presentations from clinicians, researchers, representatives from the health insurance and pharmaceutical industries, and patient advocates. Ensuring Patient Access to Affordable Cancer Drugs summarizes the presentation and discussion of the workshop."--$cSource other than Library of Congress. 606 $aHealth services accessibility$zUnited States 615 0$aHealth services accessibility 676 $a362.1782 700 $aNass$b Sharyl J.$0857626 702 $aPatlak$b Margie 712 02$aNational Cancer Policy Forum. 712 02$aBoard on Health Care Services. 712 02$aInstitute of Medicine (U.S.) 712 12$aEnsuring Patient Access to Affordable Cancer Drugs (Workshop) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910807749403321 996 $aEnsuring patient access to affordable cancer drugs$94020025 997 $aUNINA